MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) Form 8-K — Jun 3, 2026

$MRVIForm 8-KItems 1.01, 1.02, 2.03, 7.01, 9.01Filed Jun 3, 2026, 8:31 AM ET0001823239-26-000049Original filing

Maravai LifeSciences Holdings, Inc. (MRVI) entered into a new Credit Agreement on June 2, 2026, establishing a $150 million term loan and a $30 million revolving credit facility. The new debt matures on June 2, 2032, and bears interest at SOFR plus 5.00%, with a potential 0.25% stepdown if leverage ratios improve. Proceeds from the new term loan, combined with approximately $98.5 million in cash on hand, were used to fully prepay and terminate the company's prior credit agreement dated October 2020.

Key figures

Cash On Hand: 98500000
Interest Rate: SOFR + 5.00%
Maturity Date: June 2, 2032
Commitment Fee: 0.50%
Term Loan Amount: 150000000
Revolving Credit Facility: 30000000
Stepdown Margin: 0.25%
Stepdown Threshold: 3.00 to 1.00
Leverage Covenant Threshold: 6.50 to 1.00

Price after filing

1 day: +3.1%7 days: +5.0%30 days: +24.8%

Close on the filing date to close N calendar days later (from $4.84). Historical, not a forecast.

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $40.67/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.